S4E3: Myfembree for moderate-to-severe endometriosis pain: Potential for adolescents

March 2, 2022

By Lindsey Carr, Editor
Jessica Y. Shim, MD

Podcast

In this episode of Pap Talk, Contemporary OB/GYN® Associate Editor Lindsey Carr sat down with Jessica Shim, MD, an attending at in the Division of Gynecology, Department of Surgery, Boston Children’s Hospital; Harvard Medical School Boston, Massachusetts, to discuss Myfembree (relugolix, estradiol, and norethindrone acetate tablets; Myovant Sciences, Pfizer) and its possible approval in May 2022.

Watch the full interview here.

Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.

Subscribe Now!

S4E3: Myfembree for moderate-to-severe endometriosis pain: Potential for adolescents

Newsletter